TEANECK, N.J., June 17, 2016 -- Holy Name Medical Center is the first hospital in the NY/NJ metropolitan area to use digital monitoring technology to continuously track patients' vital signs. The ViSi® Mobile device, about the size of a business card, is worn on the wrist and transmits patient information to clinicians on an ongoing basis. It is the first body-worn monitor able to non-invasively measure all core vital signs including blood pressure, heart or pulse rate, electrocardiogram or heart rhythm, blood oxygenation, respiration rate and skin temperature. The system will enhance patient safety by enabling early detection of patient deterioration and help ensure a successful response to rescue situations.
"We are always looking for ways to improve the patient experience," said Sheryl Slonim, DNP, RN-BC, NEA-BC, APN-C, Executive Vice President, Patient Care Services and Chief Nursing Officer. "The monitoring system runs on the hospital's wireless network, and any abnormal changes in patients' vital signs are sent to their primary nurses so they can receive immediate attention which will help prevent adverse outcomes."
Typically, nurses check patient vital signs during routine rounds that occur every 6-8 hours. The intermittent checks can disturb patients, while only providing snapshots of vital sign data rather than continuous information. With the ViSi system, if a patient's vital signs move beyond selected ranges the system's alarm system will warn clinicians, so the appropriate intervention can be taken.
In addition to supporting safety, the system also aligns with Holy Name's ongoing efforts to improve the overall healing experience. The lightweight device promotes mobility – patients are able to get out of bed, walk around, shower and undergo physical therapy – all while remaining connected to clinicians.
"The number one benefit is improved patient safety," says Michael Maron, President and CEO. "While real-time patient monitoring is a trend that is just beginning to take hold in leading medical institutions throughout the nation, Holy Name has been testing this technology for years in conjunction with the Telemedicine and Advanced Technology Research Center of the US Department of Defense. Integrating the ViSi Mobile Technology System into our patient care model supports the hospital's long-standing commitment to delivering the highest standard of patient care and patient safety."
ABOUT HOLY NAME MEDICAL CENTER
Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, New Jersey. Founded and sponsored by the Sisters of St. Joseph of Peace in 1925, the comprehensive 361-bed medical center offers leading-edge medical practice and technology administered in an environment rooted in a tradition of compassion and respect for every patient. Holy Name provides high quality health care across a continuum that encompasses education, prevention, early intervention, comprehensive treatment options, rehabilitation and wellness maintenance. To learn more, visit HolyName.org.
CONTACT: Katherine Emmanouilidis
Director, Public Relations & Marketing
Holy Name Medical Center
718 Teaneck Road | Teaneck, NJ 07666
Tel: 201-227-6047
[email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



